TrialAnnals of clinical and translational neurology2019

Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia.

David R Lynch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.